NSAIDs and colorectal cancer risk: Do administrative data support a chemopreventive effect?

Journal of General Internal Medicine

Volumn 22, Issue 8, 2007, Pages 1166-1171

  Lamont, Elizabeth B ^a,b   Dias, Lauren E ^a,c   Lauderdale, Diane S ^d  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NORTH SHORE MEDICAL CENTER   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Aging; Colorectal cancer; Prevention

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CHOLINE SALICYLATE; DICLOFENAC; DIFLUNISAL; ETODOLAC; FENOPROFEN; FLURBIPROFEN; FLURBIPROFEN SODIUM; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC TROMETAMOL; MECLOFENAMIC ACID; MELOXICAM; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; PHENYLBUTAZONE; PIROXICAM; ROFECOXIB; SALSALATE; SULINDAC; TOLMETIN; UNCLASSIFIED DRUG; VALDECOXIB; ZOMEPIRAC;

AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHEMOPROPHYLAXIS; COLORECTAL CANCER; COMPARATIVE STUDY; DRUG EFFICACY; FEMALE; HEALTH SURVEY; HUMAN; MALE; MEDICAL CARE; MEDICARE; OSTEOARTHRITIS; POPULATION;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MEDICARE; ODDS RATIO; OSTEOARTHRITIS; SEER PROGRAM; UNITED STATES;

EID: 34447132855     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0256-7     Document Type: Article

References (43)

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin. 2005;55(1):10-30.
2. Janne P, Mayer R. Chemoprevention of colorectal cancer. N Engl J Med. 2000;342:1960-8.
3. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107:1183-8.
4. Fujita T, Matsui M, Takaku K, et al. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res. 1998;58:4823-6.
5. Labayle D, Fischer D, Vielh P, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology. 1991;101(3):635-9 (Sep).
6. Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg. 1993;80(12):1618-9 (Dec).
7. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993;328(18):1313-6.
8. Steinbach G, Lynch PM, Phillips RK, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000;342(26):1946-52.
9. Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003;348:883-90.
10. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348:891-9.
11. Chan AT, Giovannucci EL, Schernhammer ES, et al. A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med. 2004;140:157-66.
12. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst. 1991;83:355-8.
13. Sansbury LB, Millikan RC, Schroeder JC, Moorman PG, North KE, Sandler RS. Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites. Am J Epidemiol. 2005;162(6):548-58.
14. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal common cancer. N Engl J Med. 1991;325:1593-6.
15. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med. 1994;121(4):241-6.
16. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995;333(10):609-14.
17. Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 2005;294(8):914-23.
18. Sturmer T, Glynn RJ, Lee I-M, Manson JE, Buring JE, Hennekens CH. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study. Ann Intern Med. 1998;128:713-20.
19. Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005;294(1):47-55.
20. Sturmer T, Buring JE, Lee IM, Kurth T, Gaziano JM, Glynn RJ. Colorectal cancer after start of non-steroidal anti-inflammatory drug use. Am J Med. 2006;119(6):494-502.
21. National Center for Health Statistics. NAMCS description. Available at: http://www.cdc.gov/nchs/about/major/ahcd/namcsdes.htm. Accessed January 22, 2007.
22. National Center for Health Statistics. NAMCS data collection and processing. http://www.cdc.gov/nchs/about/major/ahcd/impnam.htm. Accessed April 4, 2007.
23. National Cancer Institute. SEER-Medicare linked database. Available at: http://healthservices.cancer.gov/seermedicare/. Accessed January 22, 2007.
24. National Cancer Institute. SEER: surveillance epidemiology and end results. Available at: http://seer.cancer.gov/. Accessed January 22, 2007.
25. Hatten J. Medicare's common denominator: the covered population. Health Care Financ Rev. 1980;53-64.
26. Katz JN, Barrett J, Liang MH, et al. Sensitivity and positive predictive value of Medicare part B physician claims for rheumatologic diagnoses and procedures. Arthritis Rheum. 1997;40(9):1594-600.
27. Mahomed NN, Barrett J, Katz JN, Baron JA, Wright J, Losina E. Epidemiology of total knee replacement in the United Sates Medicare population. J Bone Jt Surg. 2005;87A(6):1222-8.
28. Quam JP, Michet CJ, Wilson MG, et al. Total knee arthroplasty: a population-based study. Mayo Clin Proc. 1991;66(6):589-95.
29. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003;348:891-899.
30. Giardiello FM, Hamilton SR, Krush AJ, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993;328(18):1313-6.
31. U.S. Preventive Services Task Force. Aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer. http://www.ahrq.gov/clinic/uspstf/uspsasco.htm. Accessed April 4, 2007.
32. McCashland TM, Brand R, Lyden E, de Garmo P. Gender differences in colorectal polyps and tumors. Am J Gastroenterol. 2001;96:882-6.
33. Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the U.S. Cancer. 1999;85:1670-6.
34. Anderson WF, Umar A, Brawley OW. Colorectal carcinoma in black and white race. Cancer Metastasis Rev. 2003;22:67-82.
35. Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr. Cancer statistics by race and ethnicity. CA Cancer J Clin. 1998;48:31-48.
36. Lauderdale DS, Goldberg J. The expanded racial and ethnic codes in the Medicare data files: their completeness of coverage and accuracy. Am J Public Health. 1996;86(5):712-6.
37. Fisher ES, Baron JA, Malenka DJ, Barrett J, Bubolz TA. Overcoming potential pitfalls in the use of Medicare data for epidemiologic research. Am J Public Health. 1990;80:1487-90.
38. Mitchell JB, Bubolz T, Paul JE, et al. Using Medicare claims for outcomes research. Med Care. 1994;32:JS38-51.
39. Lauderdale D, Furner SE, Miles TP, Goldberg J. Epidemiological uses of Medicare data. Epidemiol Rev. 1993;15(2):319-27.
40. Cooley HM, Stankocich J, Jones G. The association between hormonal and reproductive factors and hand osteoarthritis. Maturitas. 2003;45(4):257-65.
41. Amin S, Niu J, Guermazi A, et al. Cigarette smoking and the risk for cartilage loss and knee pain in men with knee osteoarthritis. Ann Rheum Dis. 2007;66(1):18-22.
42. Ding C, Cicuttini F, Scott F, et al. Natural history of knee cartilage defects and factors affecting change. Arch Intern Med. 2006;166(6):651-8.
43. Hirata S, Ono R, Yamada M, et al. Ambulatory physical activity, disease severity, and employment status in adult women with osteoarthritis of the hip. J Rheumatol. 2006;33(5):939-45.